Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|August 12, 2025
[Anticipation of pharmacotherapeutic problems prior to allo stem cell transplantation in patients with co-morbidities (SFGM-TC)]Nicolas Simon, Agnès Bonnin, Alexia Jouvance, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2016
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in AdultsAmandine Le Bourgeois, Pierre Peterlin, Thierry Guillaume, et al.
Bulletin Du Cancer|June 25, 2024
[Fertility preservation and hematopoietic stem cell transplantation (SFGM-TC)]Florian Chevillon, Marine Rebotier, Nathalie Dhédin, et al.
Cells|October 14, 2022
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell RecipientsBéatrice Clémenceau, Amandine Le Bourgeois, Thierry Guillaume, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case-control studyRaphaël Lecomte, Colin Deschanvres, Amandine Le Bourgeois, et al.
Vaccines|March 26, 2022
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA VaccineBéatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES StudyPierre Peterlin, Cécile Chauvin, Steven Le Gouill, et al.
Pageof 7